147 related articles for article (PubMed ID: 34813379)
1. The Myristic Acid:Docosahexaenoic Acid Ratio Versus the n-6 Polyunsaturated Fatty Acid:n-3 Polyunsaturated Fatty Acid Ratio as Nonalcoholic Fatty Liver Disease Biomarkers.
Masetto Antunes M; Godoy G; Curi R; Vergílio Visentainer J; Barbosa Bazotte R
Metab Syndr Relat Disord; 2022 Mar; 20(2):69-78. PubMed ID: 34813379
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Nonalcoholic Fatty Liver Disease with Long-Chain n-3 Polyunsaturated Fatty Acids in Humans.
Kelley NS
Metab Syndr Relat Disord; 2016 Nov; 14(9):417-430. PubMed ID: 27710160
[TBL] [Abstract][Full Text] [Related]
3. Circulating fatty acids from high-throughput metabolomics platforms as potential biomarkers of dietary fatty acids.
Rosqvist F; Fridén M; Vessby J; Rorsman F; Lind L; Risérus U
Clin Nutr; 2022 Dec; 41(12):2637-2643. PubMed ID: 36308982
[TBL] [Abstract][Full Text] [Related]
4. Erythrocyte membrane n-3 polyunsaturated fatty acids are inversely associated with the presence and progression of nonalcoholic fatty liver disease in Chinese adults: a prospective study.
Chen ZY; Liu M; Jing LP; Xiao ML; Dong HL; Chen GD; Chen YM
Eur J Nutr; 2020 Apr; 59(3):941-951. PubMed ID: 30937580
[TBL] [Abstract][Full Text] [Related]
5. Accretion of Dietary Docosahexaenoic Acid in Mouse Tissues Did Not Differ between Its Purified Phospholipid and Triacylglycerol Forms.
Adkins Y; Laugero KD; Mackey B; Kelley DS
Lipids; 2019 Jan; 54(1):25-37. PubMed ID: 30697752
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty liver disease severity and metabolic complications in obese children: impact of omega-3 fatty acids.
Spahis S; Alvarez F; Ahmed N; Dubois J; Jalbout R; Paganelli M; Grzywacz K; Delvin E; Peretti N; Levy E
J Nutr Biochem; 2018 Aug; 58():28-36. PubMed ID: 29864682
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children: where do we stand?
Spooner MH; Jump DB
Curr Opin Clin Nutr Metab Care; 2019 Mar; 22(2):103-110. PubMed ID: 30601174
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 Fatty Acids and Gut Microbiota: A Reciprocal Interaction in Nonalcoholic Fatty Liver Disease.
Shama S; Liu W
Dig Dis Sci; 2020 Mar; 65(3):906-910. PubMed ID: 32036510
[TBL] [Abstract][Full Text] [Related]
9. Associations of serum n-3 and n-6 polyunsaturated fatty acids with prevalence and incidence of nonalcoholic fatty liver disease.
Mäkelä TNK; Tuomainen TP; Hantunen S; Virtanen JK
Am J Clin Nutr; 2022 Sep; 116(3):759-770. PubMed ID: 35648467
[TBL] [Abstract][Full Text] [Related]
10. Influence of the nutritional status and oxidative stress in the desaturation and elongation of n-3 and n-6 polyunsaturated fatty acids: Impact on non-alcoholic fatty liver disease.
Videla LA; Hernandez-Rodas MC; Metherel AH; Valenzuela R
Prostaglandins Leukot Essent Fatty Acids; 2022 Jun; 181():102441. PubMed ID: 35537354
[TBL] [Abstract][Full Text] [Related]
11. [A Future Perspective on the Involvement of n-3 Polyunsaturated Fatty Acid in the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis].
Nakamoto K; Obata T; Hirasawa A; Kim KI; Kim SR; Tokuyama S
Yakugaku Zasshi; 2016; 136(4):583-9. PubMed ID: 27040343
[TBL] [Abstract][Full Text] [Related]
12. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
13. Dietary omega-3 and omega-6 polyunsaturated fatty acids modulate hepatic pathology.
Khadge S; Sharp JG; Thiele GM; McGuire TR; Klassen LW; Duryee MJ; Britton HC; Dafferner AJ; Beck J; Black PN; DiRusso CC; Talmadge J
J Nutr Biochem; 2018 Feb; 52():92-102. PubMed ID: 29175671
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic acid varies in rat skeletal muscle membranes according to fibre type and provision of dietary fish oil.
Macartney MJ; Peoples GE; Treweek TM; McLennan PL
Prostaglandins Leukot Essent Fatty Acids; 2019 Dec; 151():37-44. PubMed ID: 31756643
[TBL] [Abstract][Full Text] [Related]
15. Impact of Long-Term Supplementation with Fish Oil in Individuals with Non-Alcoholic Fatty Liver Disease: A Double Blind Randomized Placebo Controlled Clinical Trial.
Cansanção K; Citelli M; Carvalho Leite N; López de Las Hazas MC; Dávalos A; Tavares do Carmo MDG; Peres WAF
Nutrients; 2020 Nov; 12(11):. PubMed ID: 33147705
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 polyunsaturated fatty acid levels and dysregulations in biological stress systems.
Thesing CS; Bot M; Milaneschi Y; Giltay EJ; Penninx BWJH
Psychoneuroendocrinology; 2018 Nov; 97():206-215. PubMed ID: 30077075
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 and Omega-6 Polyunsaturated Fatty Acids in Bipolar Disorder: A Review of Biomarker and Treatment Studies.
Saunders EF; Ramsden CE; Sherazy MS; Gelenberg AJ; Davis JM; Rapoport SI
J Clin Psychiatry; 2016 Oct; 77(10):e1301-e1308. PubMed ID: 27631140
[TBL] [Abstract][Full Text] [Related]
18. A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- mice.
Depner CM; Traber MG; Bobe G; Kensicki E; Bohren KM; Milne G; Jump DB
PLoS One; 2013; 8(12):e83756. PubMed ID: 24358308
[TBL] [Abstract][Full Text] [Related]
19. Serum n-3 and n-6 polyunsaturated fatty acid profile as an independent predictor of cardiovascular events in hemodialysis patients.
Shoji T; Kakiya R; Hayashi T; Tsujimoto Y; Sonoda M; Shima H; Mori K; Fukumoto S; Tahara H; Shioi A; Tabata T; Emoto M; Nishizawa Y; Inaba M
Am J Kidney Dis; 2013 Sep; 62(3):568-76. PubMed ID: 23602192
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of long-chain n-3 polyunsaturated fatty acid supplementation on tuberculosis in mice.
Nienaber A; Ozturk M; Dolman RC; Zandberg L; Hayford FE; Brombacher F; Blaauw R; Smuts CM; Parihar SP; Malan L
Prostaglandins Leukot Essent Fatty Acids; 2021 Jul; 170():102304. PubMed ID: 34082319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
